17:07 EST Atea Pharmaceuticals (AVIR) files $500M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on AVIR: Atea Pharmaceuticals Phase 3 SUNRISE-3 trial did not meet primary endpoint